Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00503815 · ClinicalTrials.gov registry record · Phase 3
BLI-800-302: BLI-800 vs an Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy
A Phase 3 study, sponsored by Braintree Laboratories.
- Completed
- Registry status
- Phase 3
- Development phase
- 360
- Enrollment target
NCT00503815 is a Phase 3 study that has completed, run by Braintree Laboratories. The registered enrollment target is 360 participants.
The verdict
NCT00503815, a Phase 3 study, has completed, sponsored by Braintree Laboratories.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 360 participants
- Enrollment target
Study Summary
This is a randomized, parallel, multi-center, single-blind study, comparing BLI-800 to an FDA approved bowel preparation in adult subjects undergoing colonoscopy.
Interventions
- DRUG BLI-800
- DRUG Polyethylene glycol 3350 based bowel preparation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 360 participants |
| Start Date | 2007-07 |
| Est. Completion | 2007-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00503815
The ClinicalTrials.gov registry entry for NCT00503815 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 360 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Braintree Laboratories, which has 49 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which BLI-800 is the first listed.
NCT00503815 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00503815 about?
NCT00503815 is a clinical study titled "BLI-800-302: BLI-800 vs an Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy". This is a randomized, parallel, multi-center, single-blind study, comparing BLI-800 to an FDA approved bowel preparation in adult subjects undergoing colonoscopy.
What is the current status of trial NCT00503815?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 360 participants. The study started on 2007-07. Estimated completion is 2007-11.
What interventions are being tested in trial NCT00503815?
The interventions under investigation include: BLI-800 (DRUG), Polyethylene glycol 3350 based bowel preparation (DRUG).
Who is sponsoring clinical trial NCT00503815?
This trial is sponsored by Braintree Laboratories, which has 49 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.